Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus.

Toi, Norikazu; Inaba, Masaaki; Kurajoh, Masafumi; Morioka, Tomoaki; Hayashi, Noriyuki; Hirota, Tomoe; Miyaoka, Daichi; Emoto, Masanori; Yamada, Shinsuke

Toi, Norikazu; Inaba, Masaaki; Kurajoh, Masafumi; Morioka, Tomoaki; Hayashi, Noriyuki; Hirota, Tomoe; Miyaoka, Daichi; Emoto, Masanori; Yamada, Shinsuke.

Afiliação

Toi N; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Inaba M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Kurajoh M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Morioka T; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Hayashi N; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Hirota T; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Miyaoka D; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Emoto M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Yamada S; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.

J Clin Transl Endocrinol ; 15: 37-44, 2019 Mar.

Article em En | MEDLINE | ID: mdl-30619717

Palavras-chave

AHI, ApneaHypopnea Index; AUC, area under the curve; Autonomic nervous function; BMI, body mass index; CGM, continuous glucose monitoring; CPR, C-peptide immunoreactivity; CVR-R, coefficient of variation of RR intervals; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; Dawn phenomenon; EEG, electroencephalography; Glycemic control; HOMA-IR, homeostasis model assessment of insulin resistance; HR, heart rate; HRV, heart rate variability; HbA1c, glycated hemoglobin A1c; IQR, interquartile range; IRI, immunoreactive insulin; Insulin resistance; PSQI, Pittsburgh Sleep Quality Index; REM, rapid eye movement; SAS, Sleep Apnea Syndrome; SD, standard deviation; SDNN, standard deviation of the NN (i.e., R-R) intervals; T2DM, type 2 diabetes mellitus; Therapy for insomnia; Type 2 diabetes mellitus; bpm, beats per minute; eGFR, estimated glomerular filtration ratio

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Transl Endocrinol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google